Sanofi’s Latest Credit Facility Offers Win-Win Model For Pharma And Society

French phama pioneers sustainable finance in pharma with $8bn in new credit facilities tied to polio eradication and carbon reduction.

handshake green business

Sanofi has signed an $8bn revolving credit facility agreement under which it stands to make savings on its margin repayment obligations if it achieves specific sustainability targets.

Hitherto uncommon in the pharma industry, sustainable finance is gathering pace in the wider corporate world as national and supranational...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from ESG

More from HBW Insight